Skip to main content
. Author manuscript; available in PMC: 2009 Jul 14.
Published in final edited form as: Obesity (Silver Spring). 2009 Feb 19;17(6):1240–1246. doi: 10.1038/oby.2009.4

Table 2.

Unadjusted Spearman correlation coefficients between risk factors and liver-spleen ratio, and p-value for ethnic interaction, IRAS Family Study, excluding persons with diabetes

Hispanic African American
r P-value r P-value p-value for interaction
Age at follow-up (yrs) 0.09 0.03 −0.09 0.13 0.07
Liver Density (HU) 0.84 <0.0001 0.76 <.0001 0.29
BMI (kg/m2) −0.44 <0.0001 −0.13 0.03 <.0001
VAT (cm3) −0.43 <0.0001 −0.24 <.0001 0.002
SAT (cm3) −0.27 <0.0001 −0.07 0.27 <.0001
Percent Total Body Fat −0.07 0.09 0.06 0.30 0.02
Fasting insulin (mg/dl) −0.43 <0.0001 −0.23 0.0001 <.0001
Fasting glucose (mg/dl) −0.27 <0.0001 −0.05 0.39 0.0001
HDL (mg/dl) 0.38 <0.0001 0.14 0.02 0.02
TG (mg/dl) −0.30 <0.0001 −0.19 0.001 <.0001
PAI-1 (ng/ml) −0.40 <0.0001 −0.09 0.13 <.0001
ALT (IU/L) −0.46 <0.0001 −0.24 0.0001 0.0001
AST (IU/L) −0.32 <0.0001 −0.17 0.003 0.02
GGT (IU/L) −0.30 <0.0001 −0.22 0.0002 0.36
Insulin Sensitivity Index * 0.43 <0.0001 0.25 <.0001 0.0007
Acute Insulin Response * −0.22 <0.0001 −0.08 0.22 0.01
Disposition Index * 0.22 <0.0001 0.15 0.01 0.002
Adiponectin (mg/ml) * 0.31 <0.0001 0.29 <.0001 0.91
CRP (mg/ml) * −0.27 <0.0001 −0.08 0.17 0.01
*

Data obtained five years prior to NAFLD assessment.